CoChat

Is dienogest the best medical treatment for ovarian endometriomas? Results of a multicentric case control study

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Abstract

Ovarian endometriomas are common manifestations of endometriosis. Surgical excision has been shown to potentially decrease ovarian reserves. In this prospective study, we included 81 patients with ovarian endometriosis. 40 were treated with 2 mg of dienogest daily (DNG) and 41 were treated with cyclic oral estro-progestins (ethinyl estradiol 30 mcg [EE] plus dienogest 2 mg) (DNG + EE). Aim of the study was the effect of the treatment on the size of the endometriotic cysts. Further, in the symptomatic patients, follow-up included an evaluation of chronic pain before and during treatment. Both treatments were able to significantly decrease the pain in symptomatic patients with no statistical differences. The mean visual analog scale score at enrollment was 65 ± 14 and 70 ± 18, and there was significant improvement (19 ± 15, p < .001, DNG; 18 ± 12, p < .001, DNG + EE). The size of the endometrioma cysts were significantly reduced in the DNG group. The mean cyst diameter was 52 ± 22 mm at baseline and 32 ± 12 mm after six months of treatment (p < .001), yielding a 75% volume reduction in DNG group. The decrease in the size of endometrioma cysts observed in the women treated with only progestin could be noteworthy, as it may reduce the negative impacts on the affected ovary and avoid surgery.

Overview

Integrity signals

Registry

Crossref · 10.1080/09513590.2019.1640674

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 24 references

Research works printed but not linked: 2

  1. Angioni S, 2017, Minerva Ginecol, 60, 438
  2. Melis GB, 2005, Giorn It Ost Gin, 27, 293

Cited by

See all 62

Metadata

Authors
Angioni, S., Pontis, A., Malune, M. E., Cela, V., Luisi, S., Litta, P., Vignali, M., & Nappi, L.
Affiliations
  • University of Cagliari (IT)
  • Department of Obstetrics and Gynecology, San Francesco Hospital, Nuoro, Italy;
  • University of Pisa (IT)
  • University of Siena (IT)
  • University of Padua (IT)
  • Macedonio Melloni Hospital, Milano, Italy;
  • University of Foggia (IT)
Corresponding author
Angioni, Stefano
Venue
Gynecological Endocrinology
Published
2019-07-16
Volume
36
Issue
1
Pages
84-86
ISSN
  • 0951-3590 (ISSN-L)
  • 1473-0766
OpenAlex
W2962367112
Cited by
55
References
24
Citations by year
2026: 3 · 2025: 8 · 2024: 10 · 2023: 13 · 2022: 8 · 2021: 10 · 2020: 3
FWCI
5.02
Type
journal article
Language
en
Open access
closed
Locations
  • Gynecological Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
  • UNICA IRIS Institutional Research Information System (University of Cagliari) (submittedVersion)
  • Padua Research Archive (University of Padova) (submittedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gynecological conditions and treatments
  • Health Sciences › Medicine › Obstetrics and Gynecology › Ectopic Pregnancy Diagnosis and Management
Keywords
dienogest, endometrioma, endometriosis, oral progestogens, ethinyl estradiol, chronic pelvic pain, ovarian reserve
MeSH terms
Adult, Contraceptives, Oral, Combined, Endometriosis, Ethinyl Estradiol, Female, Hormone Antagonists, Humans, Nandrolone, Ovarian Diseases, Case-Control Studies, Treatment Outcome, Pelvic Pain, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Is dienogest the best medical treatment for ovarian endometriomas? Results of a multicentric case control study. https://app.cochat.ai/papers/10.1080/09513590.2019.1640674
The paper
Angioni, S., Pontis, A., Malune, M. E., Cela, V., Luisi, S., Litta, P., Vignali, M., & Nappi, L. (2020). Is dienogest the best medical treatment for ovarian endometriomas? Results of a multicentric case control study. Gynecological Endocrinology. https://doi.org/10.1080/09513590.2019.1640674

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.